Benecel
They are HPMC products with optimized polymer structure and particle morphology that enable the formulation of safe, effective, and robust oral solid controlled-release dosage forms.
| Substitution Type | Grade | Average Molecular Weight | Solution Concentration (%) | Viscosity (mPa*s) |
|---|---|---|---|---|
|
2910 "E" Type |
E4M Pharm,
E4M Pharm CR |
400,000 |
2 |
2,700 - 5,000 |
|
2910 "E" Type |
E10M Pharm, E10M Pharm CR |
746,000 |
2 |
7,500 - 14,000 |
|
2208 "K" Type |
K100LV PH PRM |
164,000 |
2 |
80 - 120 |
|
2208 "K" Type |
K250 PH PRM |
200,000 |
2 |
200 - 300 |
|
2208 "K" Type |
K750 PH PRM |
250,000 |
2 |
562 - 1050 |
|
2208 "K" Type |
K1500 PH PRM |
300,000 |
2 |
1,125 - 2,100 |
|
2208 "K" Type |
K4M Pharm XR, K4M Pharm XRF |
400,000 |
2 |
2,700 - 5,040 |
|
2208 "K" Type |
K15M Pharm XR, K15M Pharm XRF |
575,000 |
2 |
13,500 - 25,200 |
|
2208 "K" Type |
K35M Pharm |
675,000 |
2 |
26,250 - 49,000 |
|
2208 "K" Type |
K100M Pharm XR, K100M Pharm XRF |
1,000,000 |
2 |
75,000 - 140,000 |
|
2208 "K" Type |
K200M Pharm XR |
1,200,000 |
2 |
150,000 - 280,000 |
Bencel Directly Compressible Hypromellose (HPMC)
| Substitution Type | Grade | Average Molecular Weight | Solution Concentration (%) | Viscosity (mPa*s) |
|---|---|---|---|---|
|
2208 "K" Type |
K4M PH DC |
400,000 |
2 |
2,700 - 5,000 |
|
2208 "K" Type |
K15M PH DC |
575,000 |
2 |
13,500 - 25,200 |
|
2208 "K" Type |
K100M PH DC |
1,000,000 |
2 |
75,000 - 140,000 |
